10 Oct 2024
// PRESS RELEASE
10 Oct 2024
// PRESS RELEASE
10 Oct 2024
// PRESS RELEASE
Latest Content by PharmaCompass
01 1Abemaciclib
02 1Acenocoumarol
03 1Acetazolamide
04 1Alendronate Sodium
05 1Aniracetam
06 1Antazoline HCl
07 1Antazoline Mesylate
08 1Antazoline Sulfate
09 1Apixaban
10 1Apremilast
11 2Aripiprazole
12 1Aripiprazole Lauroxil
13 1Avanafil
14 1Baclofen
15 1Baricitinib
16 1Brexpiprazole
17 2Carbamazepine
18 1Carfilzomib
19 1Carvedilol
20 1Carvedilol Phosphate
21 1Clemastine
22 1Clopamide
23 1Dapagliflozin
24 1Dapagliflozin Propanediol Monohydrate
25 1Denotivir
26 1Elagolix Sodium
27 1Empagliflozin
28 1Enzalutamide
29 1Etodolac
30 1Hydrochlorothiazide
31 2Ibandronate Sodium
32 1Isavuconazonium Sulfate
33 1Lamotrigine
34 1Linagliptin
35 1Molsidomine
36 1Naldemedine
37 1Nefopam Hydrochloride
38 1Opipramol Dihydrochloride
39 1Oxcarbazepine
40 1Ozanimod Hydrochloride
41 1Palbociclib
42 1Pentoxifylline
43 1Phenyl Salicylate
44 1Pimavanserin Tartrate
45 1Piracetam
46 1Risedronate Sodium
47 1Rivaroxaban
48 1Sacubitril-Valsartan
49 1Safinamide Mesylate
50 1Salicylamide
51 1Sildenafil Citrate
52 1Sitagliptin Hydrochloride
53 1Sodium Salicylate
54 1Solifenacin Succinate
55 1Sulfiram
56 1Tadalafil
57 1Ticagrelor
58 1Tolterodine Tartrate
59 1Topiramate
60 1Trametinib
61 1Undecylenic acid monoethanolamide
62 1Vardenafil Hydrochloride
63 1Vismodegib
64 1Xylometazoline Hydrochloride
65 1Zoledronic Acid
01 39Active
02 29Blank
01 26Valid
02 42Blank
01 1218MF11020
02 1220MF10241
03 1221MF10220
04 1222MF10015
05 1225MF10011
06 1225MF10034
07 1225MF10101
08 1228MF10228
09 1230MF10014
10 1231MF10080
11 1302MF10011
12 1303MF10116
13 1305MF10084
14 1306MF10013
15 54Blank
01 68Blank
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 10383
Submission : 1993-07-30
Status : Active
Type : II
Certificate Number : R1-CEP 2010-371 - Rev 02
Issue Date : 2020-08-04
Type : Chemical
Substance Number : 454
Status : Valid
Registration Number : 306MF10013
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2024-01-24
Latest Date of Registration :
NDC Package Code : 12658-0359
Start Marketing Date : 1982-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (40kg/40kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2020-10-19
Registration Number : 20201019-210-J-595
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Available Reg. Filing : ASMF |